Literature DB >> 26166574

Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.

Ze-Yi Zheng1, Lin Tian2, Wen Bu1, Cheng Fan3, Xia Gao1, Hai Wang1, Yi-Hua Liao4, Yi Li5, Michael T Lewis5, Dean Edwards6, Thomas P Zwaka7, Susan G Hilsenbeck1, Daniel Medina6, Charles M Perou3, Chad J Creighton8, Xiang H-F Zhang5, Eric C Chang9.   

Abstract

Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that wild-type N-RAS is overexpressed in BLBCs but not in other breast cancer subtypes. Repressing N-RAS inhibits transformation and tumor growth, whereas overexpression enhances these processes even in preinvasive BLBC cells. We identified N-Ras-responsive genes, most of which encode chemokines; e.g., IL8. Expression levels of these chemokines and N-RAS in tumors correlate with outcome. N-Ras, but not K-Ras, induces IL-8 by binding and activating the cytoplasmic pool of JAK2; IL-8 then acts on both the cancer cells and stromal fibroblasts. Thus, BLBC progression is promoted by increasing activities of wild-type N-Ras, which mediates autocrine/paracrine signaling that can influence both cancer and stroma cells.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26166574      PMCID: PMC4512851          DOI: 10.1016/j.celrep.2015.06.044

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  47 in total

Review 1.  Spatial segregation of Ras signaling: new evidence from fission yeast.

Authors:  Eric C Chang; Mark R Philips
Journal:  Cell Cycle       Date:  2006-09-01       Impact factor: 4.534

2.  JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer.

Authors:  Adrian Britschgi; Rita Andraos; Heike Brinkhaus; Ina Klebba; Vincent Romanet; Urs Müller; Masato Murakami; Thomas Radimerski; Mohamed Bentires-Alj
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 3.  Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.

Authors:  Y Li; W P Hively; H E Varmus
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

4.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer.

Authors:  Sangjun Lee; Sheila Stewart; Iris Nagtegaal; Jingqin Luo; Yun Wu; Graham Colditz; Dan Medina; D Craig Allred
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

6.  The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.

Authors:  Hai Wang; Cuijuan Yu; Xia Gao; Thomas Welte; Aaron M Muscarella; Lin Tian; Hong Zhao; Zhen Zhao; Shiyu Du; Jianning Tao; Brendan Lee; Thomas F Westbrook; Stephen T C Wong; Xin Jin; Jeffrey M Rosen; C Kent Osborne; Xiang H-F Zhang
Journal:  Cancer Cell       Date:  2015-01-15       Impact factor: 31.743

7.  A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.

Authors:  Xiaomei Zhang; Sofie Claerhout; Aleix Prat; Lacey E Dobrolecki; Ivana Petrovic; Qing Lai; Melissa D Landis; Lisa Wiechmann; Rachel Schiff; Mario Giuliano; Helen Wong; Suzanne W Fuqua; Alejandro Contreras; Carolina Gutierrez; Jian Huang; Sufeng Mao; Anne C Pavlick; Amber M Froehlich; Meng-Fen Wu; Anna Tsimelzon; Susan G Hilsenbeck; Edward S Chen; Pavel Zuloaga; Chad A Shaw; Mothaffar F Rimawi; Charles M Perou; Gordon B Mills; Jenny C Chang; Michael T Lewis
Journal:  Cancer Res       Date:  2013-06-04       Impact factor: 12.701

8.  Nuclear JAK2.

Authors:  Mark A Dawson; Andrew J Bannister; Lindsay Saunders; Omar-Abdel Wahab; Fan Liu; Stephen D Nimer; Ross L Levine; Berthold Göttgens; Tony Kouzarides; Anthony R Green
Journal:  Blood       Date:  2011-12-22       Impact factor: 22.113

9.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.

Authors:  Katrina Podsypanina; Yi Li; Harold E Varmus
Journal:  BMC Med       Date:  2004-06-15       Impact factor: 8.775

View more
  19 in total

1.  Ras Signaling in Breast Cancer.

Authors:  Aree Moon
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.

Authors:  Wen Bu; Zhenyu Liu; Weiyu Jiang; Chandandeep Nagi; Shixia Huang; Dean P Edwards; Eunji Jo; Qianxing Mo; Chad J Creighton; Susan G Hilsenbeck; Andrew D Leavitt; Michael T Lewis; Stephen T C Wong; Yi Li
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

3.  Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.

Authors:  Jin-Wook Kang; Min-Ji Kim; Hyun-Ah Baek; Jeong-Sang Lee
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

4.  Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer.

Authors:  Charli Dominguez; Kristen K McCampbell; Justin M David; Claudia Palena
Journal:  JCI Insight       Date:  2017-11-02

5.  The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.

Authors:  X Y Pan; X J Liu; J Li; S J Zhen; D X Liu; Q Feng; W X Zhao; Y Luo; Y L Zhang; H W Li; J L Yang
Journal:  Gene Ther       Date:  2016-12-22       Impact factor: 5.250

6.  Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.

Authors:  Ze-Yi Zheng; Meenakshi Anurag; Jonathan T Lei; Jin Cao; Purba Singh; Jianheng Peng; Hilda Kennedy; Nhu-Chau Nguyen; Yue Chen; Philip Lavere; Jing Li; Xin-Hui Du; Burcu Cakar; Wei Song; Beom-Jun Kim; Jiejun Shi; Sinem Seker; Doug W Chan; Guo-Qiang Zhao; Xi Chen; Kimberly C Banks; Richard B Lanman; Maryam Nemati Shafaee; Xiang H-F Zhang; Suhas Vasaikar; Bing Zhang; Susan G Hilsenbeck; Wei Li; Charles E Foulds; Matthew J Ellis; Eric C Chang
Journal:  Cancer Cell       Date:  2020-03-05       Impact factor: 31.743

7.  Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.

Authors:  Shuang Bai; Qiang Feng; Xin-Yan Pan; Hong Zou; Hao-Bin Chen; Peng Wang; Xin-Liang Zhou; Yan-Ling Hong; Shu-Ling Song; Ju-Lun Yang
Journal:  Int J Mol Med       Date:  2017-02-21       Impact factor: 4.101

8.  Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma.

Authors:  Harish Potu; Luke F Peterson; Malathi Kandarpa; Anupama Pal; Hanshi Sun; Alison Durham; Paul W Harms; Peter C Hollenhorst; Ugur Eskiocak; Moshe Talpaz; Nicholas J Donato
Journal:  Nat Commun       Date:  2017-02-15       Impact factor: 14.919

9.  Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.

Authors:  Gary L Johanning; Gabriel G Malouf; Xiaofeng Zheng; Francisco J Esteva; John N Weinstein; Feng Wang-Johanning; Xiaoping Su
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

10.  Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Authors:  A N Johnston; W Bu; S Hein; S Garcia; L Camacho; L Xue; L Qin; C Nagi; S G Hilsenbeck; J Kapali; K Podsypanina; J Nangia; Y Li
Journal:  Breast Cancer Res       Date:  2018-05-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.